Patent ID: 9101529
Filing Date: 2015-08-11
Classification: A61J,A61K,Y10T

Abstract:
1. A plastic container containing a pharmaceutical composition comprising sodium benzoate and an oxicam-type COX-inhibitor or a pharmaceutical acceptable salt thereof, wherein: the pharmaceutical composition is a suspension; said plastic container is formed of a container material selected from one or more members of the group consisting of a homopolymer of polypropylene (PP), a copolymer of polypropylene (PP), a homopolymer of polyethylene terephthalate (PET) and a copolymer of polyethylene terephthalate (PET); said container material does not include high-density polyethylene (HDPE), low-density polyethylene (LDPE), or polycarbonate (PC); and a loss in concentration (mg/mL) of sodium benzoate in said pharmaceutical composition due to adsorption onto said plastic container when stored for a period of 6 months at 25° C. and a relative humidity of 60% is no more than 5%.